Cytokine armored CAR T cells for cancer immunotherapy
Journal Title
Immunology and Cell Biology
Publication Type
Online publication before print
Abstract
Cytokine armoring of CAR T cells for enhancing the immunotherapy of cancer. Reprogramming of CAR T-cell phenotypes through (a) IL-15(8) or (b) IL-9Rα(9) engineering. Reprogramming of the tumor microenvironment and recruitment of host antitumor immunity through (c) IL-36γ(10) or (d) IL-12(11,12) engineering. (e) Tumor-inducible cytokine expression utilizing synthetic NFAT or endogenous NR4A2 promoter systems to restrict systemic expression of potent cytokines for improved safety.
Keywords
CAR T cells; cytokine armoring; tumor microenvironment
Department(s)
Laboratory Research
Open Access at Publisher's Site
https://doi.org/10.1111/imcb.70112
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2026-04-14 03:18:23
Last Modified: 2026-04-14 03:18:35
An error has occurred. This application may no longer respond until reloaded. Reload 🗙